GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, talked with UVA Today about the newest study and shared ways people can ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.

A study found people who took vitamin D supplements were less likely to develop dementia. But experts said other factors may have been the reason for the reduced risk.

Time-restricted eating (TRE) may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet ...

Scientists at the University of Virginia have uncovered how different exercise intensifies the impact of the hunger hormone ghrelin in the body.

Three experts explain what to watch for and how to correct low stores of this B vitamin. By Jenny McCoy Feeling ...